Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/14304
Título : Pharmacotherapies for parkinson's disease symptoms related to cholinergic degeneration
Autor : Pérez Lloret, Santiago 
Peralta, María Cecilia 
Barrantes, Francisco José 
Palabras clave : TRATAMIENTO MEDICOENFERMEDAD DE PARKINSONNEURODEGENERACIONDETERIORO COGNITIVODEMENCIA
Fecha de publicación : 2016
Editorial : Taylor & Francis
Cita : Pérez Lloret, S., Peralta, M.C., Barrantes, F.J. Pharmacotherapies for parkinson's disease symptoms related to cholinergic degeneration [en línea]. Expert Opinion on Pharmacotherapy. 2016, 17(18) doi:10.1080/14656566.2016.1254189 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/14304
Resumen : Abstract: Dopamine depletion is one of the most important features of Parkinson's Disease (PD). However, insufficient response to dopaminergic replacement therapy suggests the involvement of other neurotransmitter systems in the pathophysiology of PD. Cholinergic degeneration contributes to gait impairments, cognitive impairment, psychosis, and REM-sleep disturbances, among other symptoms. Areas covered: In this review, we explore the idea that enhancing cholinergic tone by pharmacological or neurosurgical procedures could be a first-line therapeutic strategy for the treatment of symptoms derived from cholinergic degeneration in PD. Expert opinion: Rivastigmine, a drug that increases cholinergic tone by inhibiting the enzyme cholinesterase, is effective for dementia, whereas the use of Donepezil is still in the realm of investigation. Interesting results suggest the efficacy of these drugs in the treatment of gait dysfunction. Evidence on the clinical effects of these drugs for psychosis and REM-sleep disturbances is still weak. Stimulation of the pedunculo-pontine tegmental nuclei (which provide cholinergic innervation to the brain stem and subcortical nuclei) has also been used with some success for the treatment of gait dysfunction. Anticholinergic drugs should be used with caution in PD, as they may aggravate cholinergic symptoms. Notwithstanding, in some patients they might help control parkinsonian motor symptoms.
URI : https://repositorio.uca.edu.ar/handle/123456789/14304
ISSN : 1465-6566
1744-7666 (online)
Disciplina: MEDICINA
DOI: 10.1080/14656566.2016.1254189
Derechos: info:eu-repo/semantics/closedAccess
Aparece en las colecciones: Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato Usuarios registrados haga click en: Login
pharmacotherapies-for-parkinson.pdf1,08 MBAdobe PDF  
thumb.pdf160,41 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro Dublin Core completo del ítem

Visualizaciones de página(s)

83
comprobado en 28-mar-2024

Descarga(s)

18
comprobado en 28-mar-2024

Google ScholarTM

Consultar


Altmetric


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons